WCG IPO Presentation Deck
Increasing Client Expansion Through Cross-Selling (2016 to 2021)
2016 Q1
Customer
#
1
CRO
2 Large Blopharm.a
3
CRO
4 Large Biopharma
5 Large Blopharma
6
Large Biopharma
CRO
7
8
Large Biopharma
9 Large Biopharma
10 Large Biopharma
11 Large Biopharma
12 Large Biopharma
13 CRO
14 Large Biopharma
15 Large Blopharma
16 Large Biopharma
17 CRO
18 Large Biopharma
19 CRO
20 CRO
21 Large Biopharma
22 CRO
23 Large Biopharma
24 CRO
25 Large Blopharma
26 CRO
27 Institution
28 Large Biopharma
29 Large Biopharma
30 Institution
33
IRB
Feasibility.
Selection &
Contracts &
Budgets
Benchmarking
& Analytics
eCOA/ePRO
Assessment
Adjudication &
Drug Safety
Services
SafetyPortal
Market Insights
MSA?
Duration of
Relationship
(Years)
15
18
10
12
13
8
17
22
8
9
12
20
10
11
20
18
21
8
14
22
9
12
11
9
2021 Q1
w
NL
wcg
Top 30
Accounts
MSAs with 29 of Top
30 Accounts
Bookings growing at
a 30% compound
annual growth rate
from 2018 to Q1
2021
Resilient through
pandemic - Bookings
in 2020 grew at 20%
$1.6bn
opportunity from
expanding existing
solutions within top
25 clientsView entire presentation